Blood Component Removal

"Blood Component Removal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Any procedure in which blood is withdrawn from a donor, a portion is separated and retained and the remainder is returned to the donor.

Descriptor ID	D001781
MeSH Number(s)	E02.120
Concept/Terms	Blood Component Removal Blood Component Removal Blood Component Removals Component Removal, Blood Component Removals, Blood Removal, Blood Component Removals, Blood Component Pheresis Phereses Apheresis Aphereses

Below are MeSH descriptors whose meaning is more general than "Blood Component Removal".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Blood Component Removal [E02.120]

Below are MeSH descriptors whose meaning is related to "Blood Component Removal".

Below are MeSH descriptors whose meaning is more specific than "Blood Component Removal".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Blood Component Removal" by people in this website by year, and whether "Blood Component Removal" was a major or minor topic of these publications.

Bar chart showing 9 publications over 8 distinct years, with a maximum of 2 publications in 2012

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	0	1	1
1997	1	0	1
2010	0	1	1
2011	0	1	1
2012	1	1	2
2014	1	0	1
2021	0	1	1
2022	1	0	1

Below are the most recent publications written about "Blood Component Removal" by people in Profiles.

Al-Mousily MF, Nicoara O, Selewski DT, Nadig S, Twombley K. Low-density lipoprotein apheresis for recurrent focal segmental glomerulosclerosis post renal transplant in pediatric patients. J Clin Apher. 2022 Aug; 37(4):411-414.

View in: PubMed
Jacob RP, Walsh EM, Maslak PG, Giralt SA, Avecilla ST. A simplified CD34+ based preharvest prediction tool for HPC(A) collection. Transfusion. 2021 05; 61(5):1525-1532.

View in: PubMed
Schade H, Chhabra S, Kang Y, Stuart RK, Edwards KH, Kramer C, Butcher C, Littleton A, Schneider M, Budisavljevic MN, Costa LJ. Similar dynamics of intraapheresis autologous CD34+ recruitment and collection efficiency in patients undergoing mobilization with or without plerixafor. Transfusion. 2014 Dec; 54(12):3131-7.

View in: PubMed
Povsic TJ, Losordo DW, Story K, Junge CE, Schatz RA, Harrington RA, Henry TD. Incidence and clinical significance of cardiac biomarker elevation during stem cell mobilization, apheresis, and intramyocardial delivery: an analysis from ACT34-CMI. Am Heart J. 2012 Nov; 164(5):689-697.e3.

View in: PubMed
Costa LJ, Kramer C, Hogan KR, Butcher CD, Littleton AL, Shoptaw KB, Kang Y, Stuart RK. Pegfilgrastim- versus filgrastim-based autologous hematopoietic stem cell mobilization in the setting of preemptive use of plerixafor: efficacy and cost analysis. Transfusion. 2012 Nov; 52(11):2375-81.

View in: PubMed
Losordo DW, Henry TD, Davidson C, Sup Lee J, Costa MA, Bass T, Mendelsohn F, Fortuin FD, Pepine CJ, Traverse JH, Amrani D, Ewenstein BM, Riedel N, Story K, Barker K, Povsic TJ, Harrington RA, Schatz RA. Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circ Res. 2011 Aug 05; 109(4):428-36.

View in: PubMed
Costa LJ, Alexander ET, Hogan KR, Schaub C, Fouts TV, Stuart RK. Development and validation of a decision-making algorithm to guide the use of plerixafor for autologous hematopoietic stem cell mobilization. Bone Marrow Transplant. 2011 Jan; 46(1):64-9.

View in: PubMed
Pandit R, Lathers DM, Beal NM, Garrity T, Young MR. CD34+ immune suppressive cells in the peripheral blood of patients with head and neck cancer. Ann Otol Rhinol Laryngol. 2000 Aug; 109(8 Pt 1):749-54.

View in: PubMed
Narvios AB, Alvarez FE, Glassman A, Lichtiger B. Assessing the efficiency of leukoreduction of cellular blood components. Use of a simplified formalin-fixation and batch-counting method. Am J Clin Pathol. 1997 Jan; 107(1):111-3.

View in: PubMed
Lazarchick J, Green C. Acquired von Willebrand's disease following bone marrow transplantation. Ann Clin Lab Sci. 1994 May-Jun; 24(3):211-5.

View in: PubMed

People

Explore

Similar Concepts

Top Journals